CELEX: 62021TN0160
Language: en
Date: 2021-03-25 00:00:00
Title: Case T-160/21: Action brought on 25 March 2021 — Laboratorios Ern v EUIPO — Malpricht (APIRETAL)

31.5.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 206/31
            
         
      Action brought on 25 March 2021 — Laboratorios Ern v EUIPO — Malpricht (APIRETAL)
      (Case T-160/21)
      (2021/C 206/39)
      Language of the case: English
      
         Parties
      
      
         Applicant: Laboratorios Ern, SA (Barcelona, Spain) (represented by: T. González Martínez, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Ingrid Malpricht (Ludwigshafen, Germany)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: Applicant before the General Court
      
         Trade mark at issue: European Union word mark APIRETAL — European Union trade mark No 4 814 158
      
         Procedure before EUIPO: Cancellation proceedings
      
         Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 20 January 2021 in Case R 1004/2020-4
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  uphold the present appeal;
               
            
                  —
               
               
                  revoke the defendant’s decision of 20 March 2020;
               
            
                  —
               
               
                  annul the contested decision of 20 January 2021;
               
            
                  —
               
               
                  revoke the cancellation for non-use the EUTM no. 4 814 158 ‘APERITAL’ in relation to contested goods in Class 5 while maintaining the registration of these goods (as well as to ‘pharmaceutical preparations’);
               
            
                  —
               
               
                  order EUIPO and the other party to the appeal proceedings, should it intervene in these proceedings, to pay the costs.
               
            
         Pleas in law
      
      
                  —
               
               
                  Misinterpretation of Article 58(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council when examining the concept of genuine use of the contested mark of any of the contested goods;
               
            
                  —
               
               
                  Misinterpretation of Article 58(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council when assessing the concept of the proper reason for non-use.